Matsumoto Yoshinori, Rottapel Robert
Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON M5G 1L7, Canada; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Okayama 700-8558, Japan.
Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, ON M5G 1L7, Canada; Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5S 1A8, Canada; Department of Immunology, University of Toronto, Toronto, ON M5S 1A8, Canada; Division of Rheumatology, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Trends Mol Med. 2023 May;29(5):390-405. doi: 10.1016/j.molmed.2023.02.001. Epub 2023 Mar 20.
Modification of proteins by ADP-ribose (PARsylation) is catalyzed by the poly(ADP-ribose) polymerase (PARP) family of enzymes exemplified by PARP1, which controls chromatin organization and DNA repair. Additionally, PARsylation induces ubiquitylation and proteasomal degradation of its substrates because PARsylation creates a recognition site for E3-ubiquitin ligase. The steady-state levels of the adaptor protein SH3-domain binding protein 2 (3BP2) is negatively regulated by tankyrase (PARP5), which coordinates ubiquitylation of 3BP2 by the E3-ligase ring finger protein 146 (RNF146). 3BP2 missense mutations uncouple 3BP2 from tankyrase-mediated negative regulation and cause Cherubism, an autosomal dominant autoinflammatory disorder associated with craniofacial dysmorphia. In this review, we summarize the diverse biological processes, including bone dynamics, metabolism, and Toll-like receptor (TLR) signaling controlled by tankyrase-mediated PARsylation of 3BP2, and highlight the therapeutic potential of this pathway.
蛋白质的ADP - 核糖修饰(聚ADP - 核糖基化)由聚(ADP - 核糖)聚合酶(PARP)家族的酶催化,其中PARP1是典型代表,它控制染色质组织和DNA修复。此外,聚ADP - 核糖基化会诱导其底物的泛素化和蛋白酶体降解,因为聚ADP - 核糖基化会为E3泛素连接酶创造一个识别位点。衔接蛋白SH3结构域结合蛋白2(3BP2)的稳态水平受到端锚聚合酶(PARP5)的负调控,端锚聚合酶通过E3连接酶环指蛋白146(RNF146)协调3BP2的泛素化。3BP2错义突变使3BP2与端锚聚合酶介导的负调控脱钩,导致 cherubism,这是一种与颅面畸形相关的常染色体显性自身炎症性疾病。在这篇综述中,我们总结了由端锚聚合酶介导的3BP2聚ADP - 核糖基化所控制的多种生物学过程,包括骨动力学、代谢和Toll样受体(TLR)信号传导,并强调了该途径的治疗潜力。